Compare SLND & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLND | STXS |
|---|---|---|
| Founded | 1900 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.6M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | SLND | STXS |
|---|---|---|
| Price | $3.50 | $2.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | $4.00 |
| AVG Volume (30 Days) | 50.6K | ★ 414.9K |
| Earning Date | 11-12-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $935,461,000.00 | $30,075,000.00 |
| Revenue This Year | N/A | $24.48 |
| Revenue Next Year | $0.96 | $29.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $2.68 | $1.54 |
| 52 Week High | $5.34 | $3.59 |
| Indicator | SLND | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 51.47 |
| Support Level | $3.48 | $2.30 |
| Resistance Level | $3.92 | $2.54 |
| Average True Range (ATR) | 0.25 | 0.09 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 35.52 | 61.86 |
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.